Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2026 R&D 100 Award Winners
    • 2026 Professional Award Winners
    • 2026 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • Subscribe
    • Video
    • Webinars
    • PharmSci360
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Napster Co-Founder Makes Investment in Allergy Research

By R&D Editors | December 17, 2014

In this Oct. 17, 2011 file photo, Sean Parker, co-founder of Napster, speaks at Web. 2.0 Conference in San Francisco. The Silicon Valley entrepreneur and philanthropist has announced one of the largest private donations to allergy research through the establishment of the Sean N. Parker Center for Allergy Research at Stanford University.(AP Photo/Paul Sakuma)

Napster co-founder Sean Parker missed most of his final year in high school and has ended up in the emergency room countless times because of his deadly allergy to nuts, shellfish and other foods.

Now that the former Facebook president is the father of two small children who have a genetic basis to develop allergies, he said he wants to help find a lasting cure to allergies.

Parker announced Wednesday that he is donating $24 million over the next two years to establish an allergy research center at the Stanford University School of Medicine.

“We have been applying Band-Aids for decades by using antihistamines to treat symptoms instead of going after the root cause of allergies,” Parker said.

The Sean N. Parker Center for Allergy Research will focus on understanding the dysfunctions of the immune system that result in allergic reactions and on finding the safest and best treatments for allergies through laboratory and data research, clinical trials and community outreach.

The Silicon Valley entrepreneur said he missed most of his senior year of high school because he was hospitalized with a bronchial infection due to severe allergies and asthma. Parker said his severe allergic reactions have sent him to the hospital 14 times in the last six years.

Parker, 35, said neither his 2-year-old girl nor his 2-week-old boy have allergies but he knows they could develop them.

“Now that I’m a father, I’m sympathetic to what my parents went through,” he said. “It’s terrifying for parents to see their child go through anaphylactic shock because of an allergic reaction.”

The center will be led by Dr. Kari Nadeau, an immunology researcher who focuses on allergies on children and adults. Nadeau has developed an allergy treatment that involves giving patients micro-doses of the allergen and increasing the amount ingested – over months or years – to build tolerance overtime.

“The goal is to be able to achieve desensitization in a couple of weeks,” Parker said.

Source: Associated Press

Related Articles Read More >

Big Tech now spends almost 3x more on R&D than Big Pharma 
Inside the Lab: NARI’s Ga-68 Dolacga measures liver function CT scans can’t see
Verily secures new investment from Nvidia
How Lantern Med Digital is helping build the digital layer of Costa Rica’s medtech boom
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.

R&D World Digital Issues

Fall 2025 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

R&D 100 Awards
Research & Development World
  • Subscribe to R&D World Magazine
  • Sign up for R&D World’s newsletter
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2026 Arrowfly LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2026 R&D 100 Award Winners
    • 2026 Professional Award Winners
    • 2026 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • Subscribe
    • Video
    • Webinars
    • PharmSci360
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE